Tuberculosis vaccine

Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

4241851, 4241901, 4242341, 4242481, 435 693, 435 711, 435325, 530300, 530327, 530344, 530350, 530412, 536 237, A61K 3900, A61K 3904, C12P 2106, C07K 100

Patent

active

059550775

ABSTRACT:
The invention relates to novel secreted antigens from mycobacteria capable of evoking early (within 4 days) immunological responses from T-helper cells in the form of gamma-interferon release in memory immune animals after rechallenge infection with mycobacteria of the tuberculosis complex. The antigens are present in short term filtrates (ST-CF) from cultured mycobacteria belonging to the tuberculosis complex. One of these antigens, a polypeptide with an apparent molecular weight of 6 kDa, has been identified, and the DNA encoding the polypeptide has been cloned and sequenced. The antigens of the invention are believed useful especially in vaccines, but also in diagnostic compositions, especially for diagnosing infection with virulent mycobacteria. Also disclosed are nucleic acid fragments encoding the antigens as well as methods of immunizing animals/humans and methods of diagnosing tuberculosis.

REFERENCES:
patent: 4891315 (1990-01-01), Watson et al.
patent: 4952395 (1990-08-01), Shinnick et al.
patent: 4976958 (1990-12-01), Shinnick et al.
patent: 5026546 (1991-06-01), Hilgers et al.
patent: 5330754 (1994-07-01), Kapoor et al.
patent: 5559011 (1996-09-01), Kapoor et al.
Boswell et al Computational Molecular Biology, Oxford University Press, pp. 161-178, 1988.
Andersen et al, T-Cell Proliferative Response to Antigens Secreted by Mycobacterium tuberculosis, Infection and Immunity, vol. 59, No. 4, pp. 1558-1563, Apr. 1991.
Andersen et al, Proteins Released from Mycobacterium tuberculosis during Growth, Infection and Immunity, vol. 59, No. 6, pp. 1905-1910, Jun. 1991.
Andersen et al, Specificity of a Protective Memory Immune Response against Mycobacterium tuberculosis, Infection and Immunity, vol. 61, No. 3, pp. 844-851, Mar. 1993.
Andersen and Heron, Simultaneous electroelution of whole SDS-polyacrylamide gels for the direct cellular analysis of complex protein mixtures, Journal of Immunological Methods, vol. 161, pp. 29-39, 1993.
Flesch and Kaufmann, Mycobacterial Growth Inhibition by Interferon-y-Activated Bone Marrow Macrophages and Differential . . . tuberculosis, The Journal of Immunology, vol. 138, No. 12, pp. 4408-4413, Jun. 15, 1987.
Lefford and McGregor, Immunological Memory in Tuberculosis, Cellular Immunology, vol. 14, pp. 417-428, 1974.
Orme, Characteristics and Specificity of Acquired Immunologic Memory to Mycobacterium tuberculosis Infection The Journal of Immunology, vol. 140, No. 10, pp. 3589-3593, May 15, 1988.
G.A.W. Rock, The Role of Activated Macrophages in protection and immunopathology in Tuberculosis, Research in Microbiology vol. 141, No. 2, Feb. 1990, pp. 253-256.
Sanger, Nicklen, and Coulson, DNA Sequencing with Chain-Terminating Inhibitors, Proc. Natl. Acad. Sci USA, vol. 74, No. 12, pp. 5463-5467, Dec. 1977.
Young, Bloom, Grosskinsky, Ivanyi, Thomas and Davis, Dissection of Myobacterium Tuberculosis antigens Using recombinant DNA, Proc. Natl. Acad. Sci. USA, vol. 82, pp. 2583-2587, May 1985.
Andersen, Askgaard, Gottschau, Bennedsen, Nagai and Heron, Identification of Immunodominant Antigens during Infection with Mycobacterium tuberculosis, Scand. J. Immunol., vol. 36, pp. 823-831, 1992.
Huygen, Abramowicz, Vandenbussche, Jacobs, De Bruyn, Kentos, Drowart, Van Vooren, and Goldman, Spleen Cell Cytokine Secretion in Mycobacterium bovis BCG-Infected Mice, Infection And Immunity, vol. 60, No. 7, pp. 2880-2886, Jul. 1992.
Abou-Zeid, Ratliff, Wiker, Harboe, Bennedsen and Rook, Characterization of Fibronectin-Binding Antigens Released by Mycobacterium tuberculosis and Mycobacterium bovis BCG, Infection and Immunity, vol. 56, No. 12, pp. 3046-3051, Dec. 1988.
Borremans, De Wit, Volckaert, Ooms, De Bruyn, Huygen, Van Vooren, Stelandre, Verhofstadt, Content, Cloning, Sequence Determination, and Expression of a 32-Kilodalton-Protein Gene of Mycobacterium tuberculosis, Infection and Immunity, vol. 57, No. 10, pp. 3123-3130, Oct. 1989.
Barnes et al (Journal of Immunology vol. 148 Mar. 15, 1992 pp. 1835-1840).
Kaufman (Microbiological Sciences 4 (11) Nov. 1987 pp. 324-328).
Lazar et al (Molecular & Cellular Bio. Mar. 1988 pp. 1247-1252).
Burgess et al (J. of Cell Biology vol. III Nov. 1990 pp. 2129-2138).
Salgaller et al (Cancer Immuno. Imnuother. (1994) vol. 39 pp. 105-116).

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Tuberculosis vaccine does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Tuberculosis vaccine, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Tuberculosis vaccine will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-77585

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.